SIMVACOR®-DARNITSA

The drug slows the progression of coronary atherosclerosis and reduces both the incidence of new lesions, and probability of total occlusions of blood vessels.

learn more

SIMVACOR®-DARNITSA

Simvastatin reduces triglycerides (TG), low density lipoproteins (LDL), very low density lipoproteins (VLDL) and total cholesterol in plasma ( in the case of heterozygous family and non-family forms of hypercholesterolemia, mixed hyperlipidaemia, when elevated cholesterol is a risk factor). Drug increases content of high-density lipoproteins (HDL) , decreases the LDL/HDL ratio and total cholesterol/HDL. The drug slows the progression of coronary atherosclerosis and reduces both the incidence of new lesions, and probability of total occlusions of blood vessels.

More in instructions (Ukrainian version)
INN
Simvastatinum
Package
10 mg,20 x 10 mg film-coated tabs
Form of release
Tablets
АТС class
C10A A01

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information